NYXH · NYXOAH S A
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Market Cap
89.63M
52 Wk Range
$0.80 - $5.92
Previous Close
$0.88
Open
$0.88
Volume
173,077
Day Range
$0.86 - $0.91
Enterprise Value
39.4M
Cash
97.79M
Avg Qtr Burn
-16.57M
Insider Ownership
33.19%
Institutional Own.
31.02%
Qtr Updated
Jun 30th 2026
